Show simple item record

AuthorEkiz, Elif
AuthorOz, Emel
AuthorAbd El-Aty, A. M.
AuthorProestos, Charalampos
AuthorBrennan, Charles
AuthorZeng, Maomao
AuthorTomasevic, Igor
AuthorElobeid, Tahra
AuthorÇadırcı, Kenan
AuthorBayrak, Muharrem
AuthorOz, Fatih
Available date2023-05-14T11:20:33Z
Publication Date2023-04-01
Publication NameFoods
Identifierhttp://dx.doi.org/10.3390/foods12071512
CitationEkiz, E., Oz, E., Abd El-Aty, A. M., Proestos, C., Brennan, C., Zeng, M., ... & Oz, F. (2023). Exploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections. Foods, 12(7), 1512.‏
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85152887667&origin=inward
URIhttp://hdl.handle.net/10576/42687
AbstractGanoderma lucidum is a medicinal mushroom that has been traditionally used in Chinese medicine for centuries. It has been found to have a wide range of medicinal properties, including antioxidant, anti-inflammatory, and immune-boosting effects. Recent research has focused on the potential benefits of G. lucidum in treating metabolic disorders such as diabetes and obesity, as well as its possible role in preventing and treating infections caused by the coronavirus. Triterpenoids are a major group of bioactive compounds found in G. lucidum, and they have a range of biological activities, including anti-inflammatory and antioxidant properties. These compounds have been found to improve insulin sensitivity and lower blood sugar levels in animal models of diabetes. Additionally, G. lucidum polysaccharides have been found to reduce bodyweight and improve glucose metabolism in animal models of obesity. These polysaccharides can also help to increase the activity of certain white blood cells, which play a critical role in the body’s immune response. For coronavirus, some in vitro studies have shown that G. lucidum polysaccharides and triterpenoids have the potential to inhibit coronavirus infection; however, these results have not been validated through clinical trials. Therefore, it would be premature to draw any definitive conclusions about the effectiveness of G. lucidum in preventing or treating coronavirus infections in humans.
Languageen
PublisherMDPI
Subjectanticancer
antidiabetic
antioxidant
bioactive compounds
cardiovascular diseases
COVID-19
Ganoderma lucidum
TitleExploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections
TypeArticle
Issue Number7
Volume Number12
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record